Jeff Jonas, Sage
Blasted by PhIII failure, a struggling Sage axes 340 staffers and bunkers down to survive the storm
Four months after the critical failure of a closely-watched Phase III study, Sage Therapeutics is bringing out the ax to execute a major restructuring. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.